E

Enlivex Therapeutics Ltd
D

ENLV

1.05000
USD
0.00
(0.00%)
Market Closed
Volume
931
EPS
-1
Div Yield
-
P/E
-1
Market Cap
22,476,333
OverviewSignalsIdeasNews
Related Instruments
    A
    ALLO
    -0.19000
    (-7.71%)
    2.27500 USD
    K
    KALA
    0.01000
    (0.15%)
    6.87000 USD
    L
    LGND
    -3.790
    (-3.28%)
    111.690 USD
    O
    OTLK
    -0.09500
    (-1.73%)
    5.40500 USD
    S
    SELB
    -0.07020
    (-7.39%)
    0.88010 USD
    V
    VBIV
    0
    (0%)
    0.000000 USD
    More
News

Title: Enlivex Therapeutics Ltd

Sector: Healthcare
Industry: Biotechnology
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.